Resolved

MED-RIVASTIGMINE

GENERIC MEDICAL PARTNERS INC

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is there a shortage of MED-RIVASTIGMINE in Canada?

Not currently. The most recent shortage report for MED-RIVASTIGMINE 1.5MG is marked resolved (last updated September 23, 2026).

Can I still get this?Check with your pharmacist

StatusResolved

Same-ingredient products on fileNone found

Affected strength1.5MG

Last updated2026-09-23

What this means

Does this mean the shortage is completely over everywhere?

It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.

What should I do?

If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.

DIN

02401614

Strength

1.5MG

Dosage Form

CAPSULE

Route

ORAL

Active Ingredient

RIVASTIGMINE

Tier

Unrated

Last Updated

2026-09-23

Reason for Shortage

Demand increase for the drug.

Source

View original report on healthproductshortages.ca ↗

Other Products from GENERIC MEDICAL PARTNERS INC

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

AZITHROMYCIN FOR INJECTION

500MG · DIN 02524449

CLADRIBINE INJECTION

1MG · DIN 02494574

DAUNORUBICIN INJECTABLE SOLUTION

50MG · DIN 02501481

IRINOTECAN HYDROCHLORIDE INJECTION, USP

20MG · DIN 02452421

LEUCOVORIN CALCIUM INJECTION

10MG · DIN 02480042

LEUCOVORIN CALCIUM INJECTION

1000MG · DIN 02496925